Literature DB >> 28853092

Involvement of Semaphorin (Sema4D) in T-Dependent Activation of B Cells.

Е М Kuklina1, I V Nekrasova2, Yu V Valieva2.   

Abstract

The involvement of endogenous semaphorin (Sema4D) into the key stage of T-dependent differentiation of B cells, formation of plasmoblasts, was demonstrated in vitro in T/B cell co-culture under conditions of polyclonal activation of T cells. The effect of semaphorin was not associated with activation of high-affinity Sema4D receptor plexin B1, but involves lowaffinity receptor CD72. These data indicate that Sema4D-dependent signal regulates not only the initial stage of B-cell activation, proliferative response to the antigen, but also further differentiation of B cells into plasma cells.

Entities:  

Keywords:  Sema4D; differentiation of B cells; plasmablasts

Mesh:

Substances:

Year:  2017        PMID: 28853092     DOI: 10.1007/s10517-017-3825-8

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  3 in total

Review 1.  Semaphorins and Their Receptors: From Axonal Guidance to Atherosclerosis.

Authors:  Shuhong Hu; Li Zhu
Journal:  Front Physiol       Date:  2018-10-12       Impact factor: 4.566

2.  Tenofovir Modulates Semaphorin 4D Signaling and Regulates Bone Homeostasis, Which Can Be Counteracted by Dipyridamole and Adenosine A2A Receptor.

Authors:  Patricia Llamas-Granda; Laura Martin-Rodríguez; Raquel Largo; Gabriel Herrero-Beaumont; Aránzazu Mediero
Journal:  Int J Mol Sci       Date:  2021-10-25       Impact factor: 5.923

3.  CD72/CD100 and PD-1/PD-L1 markers are increased on T and B cells in HIV-1+ viremic individuals, and CD72/CD100 axis is correlated with T-cell exhaustion.

Authors:  Rafael Correa-Rocha; Jacobo Lopez-Abente; Carolina Gutierrez; Verónica Astrid Pérez-Fernández; Adrián Prieto-Sánchez; Santiago Moreno-Guillen; María-Ángeles Muñoz-Fernández; Marjorie Pion
Journal:  PLoS One       Date:  2018-08-30       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.